Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.570
-0.040 (-1.53%)
Nov 4, 2024, 4:00 PM EST - Market closed

Nautilus Biotechnology Analyst Ratings

Total Analysts
2
Consensus Rating
Buy
Price Target
$4.50
Upside
+75.10%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
Guggenheim
Guggenheim
Strong Buy
Initiates
$6
Strong Buy Initiates $6 +133.46% Jun 27, 2024
Jefferies
Jefferies
Hold
Initiates
$5$3
Hold Initiates $5$3 +16.73% Jun 3, 2024
Morgan Stanley
Morgan Stanley
Hold
Reiterates
$6
Hold Reiterates $6 +133.46% Aug 3, 2023
Morgan Stanley
Morgan Stanley
Hold
Maintains
$8$6
Hold Maintains $8$6 +133.46% Aug 3, 2022
Goldman Sachs
Goldman Sachs
Hold
Maintains
$4$2
Hold Maintains $4$2 -22.18% Aug 3, 2022
Goldman Sachs
Goldman Sachs
Hold
Maintains
$5$4
Hold Maintains $5$4 +55.64% Jul 14, 2022
Goldman Sachs
Goldman Sachs
Hold
Maintains
$9$5
Hold Maintains $9$5 +94.55% Apr 13, 2022
Morgan Stanley
Morgan Stanley
Hold
Initiates
$8
Hold Initiates $8 +211.28% Jan 6, 2022
Cowen & Co.
Cowen & Co.
Buy
Initiates
n/a
Buy Initiates n/a n/a Nov 2, 2021
Goldman Sachs
Goldman Sachs
Hold
Initiates
$10
Hold Initiates $10 +289.11% Aug 4, 2021
Jefferies
Jefferies
Strong Buy
Initiates
$13
Strong Buy Initiates $13 +405.84% Jul 13, 2021